[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349561-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-349561-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","investigation-of-the-anticancer-effects-and-senescence-induction-of-hesperetin-combined-with-cisplatin-in-hepatocellular-carcinoma-and-embryonic-fibroblast-cell-lines-research-article","Investigation of the Anticancer Effects and Senescence Induction of Hesperetin Combined with Cisplatin in Hepatocellular Carcinoma and Embryonic Fibroblast Cell Lines - Research Article","","Hesperetin (HST), a citrus flavanone, was assessed as a co-chemotherapeutic agent with cisplatin (Cisp) to determine synergistic cytotoxicity and selective senescence induction in hepatocellular carcinoma (HepG2) cells while evaluating effects on normal embryonic fibroblasts (NIH-3T3). Cell viability was measured by MTT, antiproliferation by colony formation, senescence by SA-β-gal, and mechanisms via flow cytometry, apoptosis assays, and Western blot. The HST-Cisp combination reduced HepG2 viability synergistically (CI \u003C 1), enhanced senescence, increased apoptosis and G2/M arrest, and altered apoptotic/proliferation proteins; NIH-3T3 cells showed minimal HST cytotoxicity and reduced senescence markers under co-treatment.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/investigation-of-the-anticancer-effects-and-senescence-induction-of-hesperetin-combined-with-cisplatin-in-hepatocellular-carcinoma-and-embryonic-fibroblast-cell-lines-research-article/349561/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/investigation-of-the-anticancer-effects-and-senescence-induction-of-hesperetin-combined-with-cisplatin-in-hepatocellular-carcinoma-and-embryonic-fibroblast-cell-lines-research-article/349561.png","ImageObject",300,407,{"name":42,"@type":43},"dhado","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of combining hesperetin with cisplatin in this study?","Question",{"text":63,"@type":64},"To evaluate synergistic cytotoxic effects against HepG2 hepatocellular carcinoma cells and selective induction of senescence, while assessing impact on normal fibroblast cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were cytotoxicity and antiproliferative effects measured?",{"text":68,"@type":64},"Cytotoxicity was measured by the MTT assay for cell viability, and antiproliferative properties were assessed using colony formation assays.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings were observed in HepG2 cells after co-treatment?",{"text":72,"@type":64},"The combination showed synergistic reduction of viability (CI \u003C 1), increased senescence with SA-β-gal, inhibited colony formation, increased apoptosis and G2/M phase arrest, and shifted related protein expression (e.g., Bax and caspase-3 upregulation with Bcl-xL downregulation).",{"name":74,"@type":61,"acceptedAnswer":75},"Did the combination harm normal fibroblast (NIH-3T3) cells in the same way?",{"text":76,"@type":64},"HST alone showed minimal cytotoxicity in NIH-3T3 cells (IC50 > 500 µM). Co-treatment with Cisp reduced senescence markers, suggesting protection against senescence in non-cancerous cells.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},349561,1790536198,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":117,"preview_page_count":33,"preview_urls":149},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:06/25/2025 Acceptance:01/30/2026 Published:02/06/2026 |\n| --- | --- |\n\nInvestigation of theAnticancer Effects and Senescence Induction of Hesperetin Combined with Cisplatin in Hepatocellular Carcinoma and Embryonic Fibroblast Cell Lines  \nAnif Nur Artanti 1,2,3, Riris Istighfari Jenie3,4 *, Rumiyati Rumiyati4, Adam Hermawan4, Kato Jun-ya5, Mila Hanifa3  \nAbstract  \nObjective: Hepatocellular carcinoma (HCC), the most common form of liver cancer, often develops in individuals with chronic liver diseases, especially cirrhosis. Cisplatin (Cisp), a chemotherapy agent commonly used in HCC treatment, is effective but is known to damage normal cells, including fibroblasts. Hesperetin (HST), a citrus flavanone found abundantly in citrus fruits, has demonstrated antioxidant, anti-inflammatory, and anticancer properties. This study aimed to investigate the synergistic cytotoxic effects and selective induction of senescence by HST in combination with Cisp in HepG2 cancer cells and NIH-3T3 fibroblast cells. Methods: The cytotoxic effects of HST were assessed using the MTT assay to determine cell viability. The antiproliferative properties were evaluated using colony formation assays. Senescence was assessed using SA-β-gal staining, while flow cytometry was used to analyze cell cycle distribution and apoptosis. Protein expression related to proliferation and apoptosis was determined via Western blot analysis. Results: MTT assay results indicated that both HST and Cisp reduced HepG2 cell viability in a dose-dependent manner, with IC50 values of 258 ± 2.47 µM and 5 ± 1.83 µM, respectively. Their combination (HST: 33–130 µM; Cisp: 0.6–2.5 µM) showed synergistic effects (combination index, CI \u003C 1) co-treatment with HST (65 and 130 µM) significantly enhanced senescence in HepG2 cells. Clonogenic assays showed inhibition of colony formation, supported by reduced expression of p-ERK1/2 and Cyclin D1. Flow cytometry revealed increased apoptosis and G2/M phase arrest, with upregulation of Bax and caspase-3, and downregulation of Bcl-xL. In NIH-3T3 cells, HST showed minimal cytotoxicity (IC50 > 500 µM), and co-treatment with Cisp reduced senescence markers. Conclusion: These results suggest that HST and Cisp co-treatment synergistically reduces cancer cell viability while protecting normal fibroblasts from senescence, supporting its potential as a co-chemotherapeutic agent in HCC treatment, while also serving as a protective agent against senescence in healthy tissues.  \nKeywords: hesperetin-cisplatin-HCC-senescence-fibroblast  \nAsian Pac J Cancer Prev, 27 (2), 557-568  \nIntroduction  \nHepatocellular carcinoma (HCC) represents the predominant form of primary liver cancer and ranks among the top global causes of cancer mortality [1] . The Asian Pacific region has an HCC prevalence of approximately 530,000 [2] . Current chemotherapeutic agents, such as cisplatin (Cisp), effectively induce cytotoxicity in cancer cells. Clinical applications extend beyond HCC to include other types of hepatic tumors. However, their lack of selectivity often results in severe side effects and toxicity in healthy tissues [3]. Thus, there  \nis a growing demand for novel therapeutic strategies that enhance the efficacy of existing treatments on HCC while minimizing adverse effects on non-cancerous cells. Hesperetin (HST), a naturally occurring flavonoid found in citrus fruits, has garnered significant attention for its wide-ranging pharmacological properties, including antiinflammatory, antioxidant, and anticancer activities [4] . Recent studies suggest that HST may potentiate the effects of conventional chemotherapeutics and exhibit selective action on cancer cells. HST exerts anticancer effects through multiple mechanisms, including the induction of apoptosis, cell cycle arrest, and the modulation of  \n1Doctoral Program in Pharmaceutical Science, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia. 2Department of P","cbCaiiwGBbFdhnw1","https://ap.wps.com/l/cbCaiiwGBbFdhnw1","pdf",1171295,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the main objective of combining hesperetin with cisplatin in this study?\",\"answer\":\"To evaluate synergistic cytotoxic effects against HepG2 hepatocellular carcinoma cells and selective induction of senescence, while assessing impact on normal fibroblast cells.\"},{\"question\":\"How were cytotoxicity and antiproliferative effects measured?\",\"answer\":\"Cytotoxicity was measured by the MTT assay for cell viability, and antiproliferative properties were assessed using colony formation assays.\"},{\"question\":\"What key findings were observed in HepG2 cells after co-treatment?\",\"answer\":\"The combination showed synergistic reduction of viability (CI \\u003c 1), increased senescence with SA-β-gal, inhibited colony formation, increased apoptosis and G2/M phase arrest, and shifted related protein expression (e.g., Bax and caspase-3 upregulation with Bcl-xL downregulation).\"},{\"question\":\"Did the combination harm normal fibroblast (NIH-3T3) cells in the same way?\",\"answer\":\"HST alone showed minimal cytotoxicity in NIH-3T3 cells (IC50 \\u003e 500 µM). Co-treatment with Cisp reduced senescence markers, suggesting protection against senescence in non-cancerous cells.\"}]","Investigation of the Anticancer Effects and Senescence Induction of Hesperetin Combined with Cisplatin in Hepatocellular Carcinoma and Embryonic Fibroblast Cell Lines - Research Article | PDF",1790084320,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7f85158c2480d4ac526c3e735fa8b5e.webp",983,1390,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c4b3ce7dd0f7923a39e040387c378f5.webp",982,1388,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbf6ba4f8e02a5d235569cbe92458f7a.webp",981,1387,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de7b055abf568eea38c7544fc6427f01.webp",980,1385]